RegenLab USA, Inc. RGNA
Annual
Quarterly
No annual revenue total was found in RegenLab USA, Inc.'s SEC filings.
RegenLab USA, Inc. (RGNA) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RGNA
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jersey City, NJ
- SEC CIK
- 2084031
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.